1.
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes
by Zoungas, Sophia
Diabetologia, 2014-09-17, Vol.57 (12), p.2465-2474
2.
3.
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
by Anderson, Simon G
Heart (British Cardiac Society), 2016-11, Vol.102 (21), p.1750-1756
4.
Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens
by Fransen, Marlene
Annals of the rheumatic diseases, 2015-05, Vol.74 (5), p.851-858
5.
Rationale and design of dal-PLAQUE: A study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fl...
by Fayad, Zahi A., PhD
The American heart journal, 2011, Vol.162 (2), p.214-221.e2
6.
A prospective, observational study of Xigris Use in the United States (XEUS)
by Steingrub, Jay S., MD
Journal of critical care, 2010, Vol.25 (4), p.660.e9-660.e16
Filter electronic articles 6 Hits
Remove Filters
- Subjects
- Aged
- Treatment Outcome
- Middle Aged
- more ...
- Risk Factors
- Male (6)
- Humans (6)
- Science & Technology (5)
- Female (5)
- Life Sciences & Biomedicine (5)
- Mortality (4)
- Adult (3)
- Type 2 Diabetes (3)
- Cardiology. Vascular System (2)
- Clinical Medicine (2)
- Cardiac & Cardiovascular Sys... (2)
- Cardiovascular System & Card... (2)
- Blood And Lymphatic Vessels (2)
- Age Factors (2)
- Biological And Medical Sciences (2)
- Blood Circulation Disorders (2)
- less ...